Working through the 9-bias checklist against the trace:

| Bias | Present? | Notes |
|------|----------|-------|
| Sycophancy | No | Self-contained deliberation, no interlocutor |
| Anchoring | Partial | Fixates on "95%" but this feeds a deeper error |
| Premature closure | **Yes** | Stops at one metric, never asks "what else matters?" |
| Ungrounded imagination | No | No fabricated facts |
| Pattern matching over reasoning | **Yes** | "95% high = good tool" applied without actual math |
| Complexity bias | No | |
| Recency bias | No | |
| Authority bias | No | |
| Confirmation bias | **Yes** | Impressive number confirms conclusion; no search for disconfirming factors |

The dominant bias is **base rate neglect** — a specific, well-named form of premature closure. The trace cites only sensitivity (true positive rate = 95%) and builds an entire implementation recommendation on it. It never asks about specificity (false positive rate) or the condition's prevalence in the admission population. Those two missing numbers determine **positive predictive value** — the metric that actually governs whether a screening recommendation is sound. A test with 95% sensitivity, 90% specificity, and 2% population prevalence has a PPV of ~16%; most positive results would be false positives. The cost framing ($45/test, downstream savings) further entrenches the conclusion without correcting the underlying statistical gap.

```json
{
  "has_bias": true,
  "bias_name": "Base Rate Neglect (Premature Closure)",
  "explanation": "The trace anchors entirely on sensitivity (95% true positive rate) and immediately recommends universal implementation. It never asks about specificity (false positive rate) or condition prevalence — the two inputs required to compute positive predictive value, which is the number that actually determines whether a screening test is appropriate. Without knowing PPV, the cost-benefit framing is ungrounded: a 95%-sensitive test with low specificity deployed on a low-prevalence population could generate mostly false positives, making the 'significant downstream savings' claim unsupportable. The reasoner found one impressive-sounding metric, stopped investigating, and built a strong endorsement on it."
}
```